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SS showed no systematicchangesoverthesame experimentalperiod. We
conclude: (1) Proportional reductions in myocardial metabolism and function
develop following repeated brief coronary occlusions (a mild preconditioning
stimulus in dogs); (2) These findings indicate that a transiently downregu-
Iated energy demand may indeed be one of the factors influencing classic
preconditioning.
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of myocardial infarct aiza by partial raduction of
blood aupply combinad with pacing of tha
gaatrocnamiua muacle
Y. Birnbaum, R.A. Kloner. Good Samaritan Hospital, University of Southern
Cdifomia, Los Angeles, CA, USA
Ischemic preconditioning, the limitation of infarct size by preceding brief
complete occlusion of the infarct related mronaty artery, is well described.
However,whether pacing-induced ischemiaof skeletal muscle can precondi-
tion the myocardium is unknown. We assessed the effect of preconditioning
at a distance, induced by partial reduction of blood flow to a hind limb
combined with muscle pacing, on myocsrdial infarct-size (IS). Anesthetized
rabbits were randomized to 30 min of: waiting period (controls); 60-70%
reduction of femoral artery blood flow (stenosis); gastrocnemiua muscle pac-
ing at a rate of I/second (pacing); or 60-70% reduction of femoral artery
flow and gastrocnemius pacing (stenosis+ pacing). Thereafter, rabbits were
subjected to 30 min of coronary attery occlusion and 4 h of reperfusion. Each
group included 8 rabbits. Risk-zone (RZ) was assessed by blue dye and
infarct-aize by tetrazolium ataining. The size of RZ was comparable among
groups. However, the ratio of IS/RZ was smaller in the stenosis + pacing
group (0.09 + 0.02), as compared with the control (0.26 + 0.03), stenosis
(0.36 + 0.05), and pacing (0.30 + 0.05) groups (p = 0.0006). Analysis of
covariance testing for group effect performed on the volume of IS and the
volume of RZ revealed a significant group effect (p = 0.0004). Peripheral
muscle stimulation combined with restriction of bleed flow, preconditioned
the myocardium. These results suggest that oxygen supply-demand imbal-
ance of a remote organ can ischemioally precondition the myocerdium at a
distance, supporting a potential humoral mechanism.
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lachemia and prevanta left ventricular dysfunction
during PTCA. Clinical access to ischemic
preconditioning?
U.E. Heidland, M.P. Heintzen, B. Schwattzkopff, B.E. Strauer.
Heinrich-Heine-University Dusseldorf, Germany
Ischemic preconditioning has been shown to protect the myocardium from a
subsequent ischemic insult. Adenosine represents an important mediator of
iachemic preconditioning. PTCA is a suitable tool to study the response of the
human myocerdium to subsequent periods of ischemia. The purpose of this
study is to evaluate, if intrecoronaty pretreatment with the adenoaine-agonist
dipyrfdamole (dip) reduces PTCA-induced ischemic complications. 46 pa-
tients (41 men, 5 women, age = 64.1 + 2.3 a) were randomised to receive
ekher conventional pretreatment or dip pretreatment (0.5 mg/kg bodyweight)
prior to PTCA for stable ischemia. Patients receiving dip tolerated longer
balloon inflation times (155.3 + 14.4s vs. 93.1 + 5.2s; p < 0.001), accom-
panied by a reduction in ST-segment elevation (0.27 + 0.01 mV va. 0.16 +
0.02 mV; p < 0.01) and a reduction in anginal pain. In 20 patients (18 men,
2 women, age = 62.6 + 2.9a) receiving randomization concerning conven-
tional pretreatment or dip, registration of hemodynamice and left ventricular
angiography were performed before and at the end of PTCA. Patients receiv-
ing conventional pretreatment exhibited a dramatic decline in left ventricular
ejection fraction during PTCA (77.2 + 2.3Y0before PTCA vs. 54.6 + 3.1%
during PTCA, p c 0.031), while dip pretreatment prevented a significant
reduction (66.0 * 4.0% before PTCA vs. 66.1 + 3.7% during PTCA, n.s.).
It ia mncluded, that intracoronaty dip increaaes tolerance to ischemia and
prevents myocardial dysfunction during PTCA. One possible explanation is
induction of iachemic preconditioning.
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776-4 Blockade of nitric oxide improve myocardial
metabolism during iechemia independent of
preconditioning effect
M. Araki, M. Tanaka, K. Hasegawa, S. Sasayama. Kyoto University Kyoto,
Jspsn
The expression of nitric oxide aynthase (NOS) can be induc&l by various
kinds of stimuli including hypoxia. Since NO has multiple biological actiona,
it may play a cerdio-toxic or -protective role in the process of myocerdial
ischemia (1)and reperfusion (R). A relatively large dose of NOS inhibitor re-
duces regional myocsrdial blood flow (RMBF) and is cardioprotective againat
subsequent ischemia by preconditioning effect. However, a role of endoge-
nous NO in I and R independent of preconditioning effect haa not been
clarified. We studied the effect of a low dose of L-nitro-arginine methyl ester
(L-NAME), a NOS inhibitor on myocardial metabolism during I and R in vivo.
In an open-chest pig model, we measured tisaue levels of ATP and pH in
the area at risk by 3’ P-nuclear magnetic reaonance spectroempy. A bolus
injection of 0.74 mol/kg of L-NAME (n = 8) into the right atria did not alter
tissue metabolism or RMBF (0.76 + 0.11 to 0.76 + 0.13, NS) meaaured by
colorsd microsphere compared with.placebo saline (n = 9). These indicate
this dosage of L-NAME did not elicit ischemic preconditioning. During sub-
sequent 15-min regional I by coronary ligation, tissue levels of pH and ATP
were significantly presemd in the L-NAME group compared with the placebo
group (pH: 6,67 + 0.06 vs 6.30 + 0.08, p <0.05 and % ATP: 74.9 + 7.5 vs
51.8 + 4.0, p < 0.05). However, the metabolism did not differ between the
L-NAME and placebo groups during subsequent 120-min R. Double products
were similar between these two groups throughout experiments. Thus, block-
ade of NO was cardioprotective in I independent of preconditioning effect,
suggesting a cytotoxic role of endogenous NO in myocardiai metabolism
during 1.
m
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Continuous administration of aminoguanldine
inhibits inducibla nitric oxide synthaae and exerts
protective affacts in a rabbit model of iachemia and
reperfusion
S.M. Wildhirtl, H. Suzuki2, D. Horstman 2, W.-P.Wolf 1, C. Schulze 1,
M. Weis’, B. Reichart 1.1 Depts. of Cardiac Surgery University ofhfurrich,
GermanK 2Huntington Medical Research Inatitute, Pasadena, CA, USA
In cardiac disorders including acute myocardial infarction or acute allograft
rejection the inducible nitric oxide synthase (iNOS) activity is significantly
increased. We investigated the effects of continuous inhibition of inducible
nitric oxide synthase (iNOS) by aminoguanidine (AG) in a model of 30 min.
of ischemia followed by 48 h of reperfusion. Eighteen male New Zealand
White rabbits were subjected to ligation of the circumflex coronary artery.
Animals were randomly assigned to the following groups: A) Sham (n =6); B)
Ischemidreperfusion + Placebo (l/R) (n =6); l/R +AG (300 mg/kg/day/sc; n =
6), Left ventricular systolic (LVSP)and diastolic pressure (LVEDP), maximum
+dP/dt and -dP/dt were monitored. Infarct aize was determined by triphenyl-
tetrazolium staining. Inducible NOS (fmol/Mg) was assayed by conversion
of L-14C-arginine to L-14C-citrulline. Tissue levels of AG were measured
by spectrophotometry. Aminoguanidine significantly inhibited iNOS activity
(Sham: 3.13 + 0.4; group B 18.73 + 2.6 vs group C: 7.34+ 1.8, p c 0.05).
Average myocardial AG-level was 15.4+ 2.6 @gtissue. Infarct aize (as per-
centage of risk area) was significantly smaller in AG treated snimals (group
B: 62.3+ 7.3%, C: 44.2 + 6.9%, p < 0.05). No hemodynamic difference be-
tween groups were noted prior to l/R but animals in group B and C developed
left ventricular dysfunction after I/R. In group C, however, LVSP and +dP/dt
were significantly higher after 48 h of l/R when compared to Group B (LVSP:
63.7 & 2.3 VS 51.1 + 5.2, p < 0.05; +dP/dt: 1852 + 624 VS 2691 + 629, p <
0,05). LVEDPwas significantly lowerin AG treated animals (3.58 zkO.8vs5.4
+ 0.7, p < 0.05). The present study provides further evidence that increased
iNOS activity contributes to myocsrdial dysfunction after I/R. Aminoguani-
dine, continuously administered, reduces infarct size and protects the hearl
against l/R induced injury.
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(l,4,5)-trisphoaphate mediates infarct size reduction
with preconditioning in isolated rabbit heart
B. Bauer, B.Z. Simkhovich, R.A. Kloner, K. Przyklenk. Heart /nst/tute, Good
Samaritan Hospita/ & USC, Los Angeles, CA, USA
The cellular mechanisms by which brief antecedent ischemia “preconditions”
(PC) the heart and limits infarct size cauaed by a subsequent sustained
period of corona~ artery occlusion (CO) remain unidentified. We propoae
that activation of the second messenger inositol (1,4,5)-trisphosphate (IP3:
a crucial mediator of calcium release from intracellular stores) during the PC
stimulus may play a focal role. To test this theory, 22 isolated Lsngendorff-
perfused rabbit hearts were subjected to 30 min of sustained CO and 2 h of
reperfusion. In Protoool 1, heatts received 2 5-rein episodes of regional PC
ischemia separated by 5 min of reflow (n =5) or a comparable control period
(n = 5) before sustained CO. Protocol 2 was identical, except neomycin
(0.16 mM: a potent and specific inhibitor of IP3 formation) was infused
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in all hearts from the onset of the PC/control period (n = 6 per group)
and terminated 2.5 min prior to CO. Coronary flow and LV pressure were
monitored throughout each protocol, and area of necrosis (AN)was assessed
by tetrazolium staining and expressed as a % of the area at risk of infarction
(AR).
ANIAR
Protocol1: Control 63 l 2%
Pc 30+ 6%**
Protocol2: Control+’Neomycin 56+ 10%
PC+ Neomycin 54* 9%
Protocol 1 confirmed the expected reduction in infarct size in PC hearts
versus controls (** p < 0.01). In contrast, in Protocol 2, infarct size was com-
parable in both control and PC hearts treated with neomycin. Impotiantly,
protection with PC - and loss of protection with neomycin - was not due to
differences in coronary flow or LV pressure among groups (data not shown).
These results support the concept that activation of the second messenger
inositol (1,4,5)-trisphosphate (and subsequent release of calcium from intra-
cellular stores) during brief antecedent ischemisJreperfusionis an important
mediator of infarct size reduction with preconditioning in this isolated rabbit
heart model.
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infsrotion: Interaction between age and right
ventricular infarction
H. Bueno, R. Lopez-Palop, J. Osende, J. Garcfa-Garcia, E. Perez-David,
J.A. Serrano, J.L. Lopez-SendOn,J.L. Delcan. Hospital General Gregorio
Marafin6n, Madrid, Spain
Itis known that patients with acute inferior myocerdial infarction (lMl) and
right ventricular infarction (RVI) have a worse prognosis than those without it
and that the elderly also have a poorer outcome. To assess the influence of
age on prognosis of IMI and its relation with RVI, we studied the in-hospital
clinical outcome of 652 consecutive patients admitted to our CCU with a
definite diagnosis of IMI of less of 46 hours of evolution and compared their
outcomes according to their age and to the presence of RVI.
Resu/ts.’Themean ageofthewhole groupwa.s73+ 13years, 80% males.
Thrombolysis was used in 47% of patients and primary PTCA in 3%. The
incidence of RVI was 35%. The total in-hospital mortality rate was 12% (20Y0
inpatients with RVI, 5% in those without, p < 0.001). A significant (p < 0.001)
mrrelation between age and mortality was found in both groups. The addition
of the interaction factor RV1-ageto the logistic regression model was only
significant in patients older than 65 year. We plotted age and mortality (Fig.)
and found an exponential increase in mortality which was only significant in
patients older than 65 years with RVI (logistic regression coefficient D:0.152,
p <0.0005. In patients without RVI, ~: 0.021, p < 0.55).
!U
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Conclusion: The in-hospital mortality of IMI is age-dependent, but this
dependence is essentially related to the precence of RVI.
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El7772 Non-Q wave myocardial infarction ia notindapandently associated with worsa outcome in the
aldarly
J.E. Murillo, J. Chen, 0. Jagasia, Y. Wang, H.M. Krumholz. YaleUrriversity
School ofhfedicirre, NewHaven, CT USA
Several studies, predominately of younger patient.s,suggeat that non-Q wave
myocardial infarction (NQWMI) has a better in-hospital outcome than Q-
wave myccerdial infarction (QWMI), but the advantage is lost over time.
To determine the association of NQWMI with outcome in the elderly, we
used the Connecticut cohort of the Cooperative Cardiovascular Project pilot
datebase which contains medical record information for Medicare patients
admitted with acute myocardial infarction (Ml). Both admission and discharge
electrocardiograms were interpreted to classify patients by the presence of
Q waves,
Among the 2,720 patients >65 years with interpretable electrocardio-
grams, 1,533 patients (56%) had an NQWMI. Patients with NQWMI had a
significantly lower in-hoepital mortality rate than QWMI (12% vs. 19%, P <
0.001). Among the 2,309 patients who survived the hospitalization, 1,350
(58%) had a NQWMI. These patients were significantly older and more likely
to have a history of Ml, CHF, diabetes, afid revascularization surgety. The
rate of cath during the initial hospitalization was 36% for the two groups. Dur-
ing the year after discharge, NQWMI patients had a mortality rate that was
not significantly different from QWMI patients (20% vs. 17%, respectively,
P = 0.12). After adjusting for demographic, clinical, pharmacological, and
electrocardiographic variables, and treatment, NQWMI was not associated
with any increased risk mmpared with QWMI (OR 0.89, 95% Cl 0.68 to
1,15, P value 0.37). The rate of readmission for any cause during the year
postdischarge was also not different for both groups: 50.6% for QWMI and
50.3% for NQWMI.
Conclusion: Among elderly hospital survivors of AMI, NQWMI does not
predict higher one-year mortality or one-year readmission when compared
to QWMI.
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~[ RagiOnalvariatiOn inmYOcardialinfarc~iOn care:~he
cooperative cardiovascular project experience
T,A. Marciniak, H.M. Krumholz. Health Care FirrarrcingAdrrrirristration,
Baltimore, MD, and Ya/aUrriversifySchool of Medicine, New Haven, CT
USA
The Health Care Financing Administration’s Cooperative Cardiovascular
Project abstracted 224,377 medical records of hospital discharges of Medi-
care patients with acute myocardial infarction (AMI) from February, 1994,
through July, 1995. These data show significant variations in care processes
and outcomes acrossthe nation when the data are analyzed by the nine Cen-
sus Bureau regions. The most striking variations are lower use of invasive
procedures in the New England region (angiography 22Y0,angioplasty 8Y.,
CABG 6%) and greater use of beta blockers at discharge (55%) compared
to the national means (angiography 36%, angioplasty 14’%.,CABG 9%, beta
blockars 39%). The variations in rates for other process measures are smaller
and more randomly distributed: reperfusion in ideal candidates (mean 66%,
range 59 to 74%); aspirin during the stay (mean 79%, range 77 to 82%) and
at discharge (mean 67%, range 65 to 71Yo); and ACE inhibitor use (mean
56%, range 52 to 64%) and calcium channel blocker avoidance (mean 64%,
range 81 to 87Yo)at discharge in patients with reduced LVEF. The 30-day
mortality rate is lowest in the New England region (15.3%), compared to the
national mean of 17.8%,and the survival advantage in New England persists
after risk adjustment (relative risk 0.8). Conclusion: Regional variations in
AMI care persist despite the availability of good national guidelines for AMI
treatment.
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-I Decisio.ma~i.gi. octogenarian~,~haracteristics
associated with selection for catheterization
following acute myocardial infarction
P.J. Higgins, D.E. Wennberg, T.J. Ryan, Jr.,C.T. Lambrew, W.J. French for
the Participants in the National Registry of Myocardial Infarction. Maine
Medical Center, Portland, MEand Hatior-UCLA, Torrance, CA, USA
Following acute Ml, pts ?80 yrs undergo cardiac catheterization (cath) less
frequently than younger pts yet have a higher overall mortality. To under-
stand post Ml decision making and resource utilization in octogenarians we
analyzed 21,354 pts ?80 yrs from the NRMI-2 regist!y admitted with Ml to
hospitals with cath facilities in the US from 11/94-1/96. Univariate and mul-
tivariate logistic regression analyses were used to assess for independent
associations with post Ml cath.
Multivariataoddsratiosfor postMl cath
Positive OR (950/0Cl) Negative OR (95”/0Cl)
PriorPTCA 1.9 (1.7, 2.3) PriorMl 0.9 (0.8, 0.99)
PriorCABG 1.3 (1.2. 1.5) PriorCHF 0.6 (0,5, 0,7)
Male Gender 1.3 ~1.2; 1.4j PriorCVA 0.6 (0.5; o.7j
RecurrentAngina 2.1 (1,9, 2.4) Shock 0.S (0.6, 0.9)
RecurrentMl 1,2 (1.01, 1.5) Hypotension 0.8 (0.7, 0,9)
ThrombelyticRx 1.3 (1.2, 1.5) CHF 0.9 (0,8, 0,99)
SBP ? 90 mmHg 1.7 (1,3, 2,2) New England 0.5 (0.4, 0.7)
